Hui Fang

The optimal neoadjuvant modality in locally advanced gastric cancer in the era of immune-drugs: a multicenter retrospective analysis

Optimal neoadjuvant strategies for locally advanced gastric cancer (LAGC) remain contentious. The purpose of this study was to compare the survival prognosis and safety of LAGC receiving three different neoadjuvant modalities. In this multicenter retrospective cohort, 670 patient...